Health & Beauty

The FINANCIAL -- Shanghai, China, September 3rd, 2018 – BeiGene Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, announced that the National Medical Products Administration of China (NMPA, formerly known as CFDA), has accepted its new drug application (NDA) for its ...

The FINANCIAL -- Amid raging wildfires in California, and as it is entered what the National Oceanic and Atmospheric Administration calls the most active and dangerous time of year for tropical ...

The FINANCIAL -- Glaucomatous neurodegeneration may stem from a case of mistaken identities after high intraocular pressure (IOP) triggers an autoimmune response that targets retinal cells, new ...